| Bioactivity | SARS-CoV-2 3CLpro-IN-17 (Compound 3h) is a selective SARS-CoV-2 3CLpro inhibitor (IC50s: 0.322 μM)[1]. |
| Target | 0.322 μM (SARS-CoV-2 3CLpro) |
| Name | SARS-CoV-2 3CLpro-IN-17 |
| Formula | C16H9N3OS2 |
| Molar Mass | 323.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ren P, et al. Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group. J Med Chem. 2023 Aug 18. |